19-11948283-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_144566.3(ZNF700):āc.259A>Gā(p.Ile87Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000548 in 1,460,588 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_144566.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF700 | NM_144566.3 | c.259A>G | p.Ile87Val | missense_variant | 4/4 | ENST00000254321.10 | NP_653167.1 | |
ZNF700 | NM_001271848.2 | c.268A>G | p.Ile90Val | missense_variant | 4/4 | NP_001258777.1 | ||
ZNF69 | XM_017027231.2 | c.500-31758A>G | intron_variant | XP_016882720.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF700 | ENST00000254321.10 | c.259A>G | p.Ile87Val | missense_variant | 4/4 | 1 | NM_144566.3 | ENSP00000254321.4 | ||
ENSG00000267179 | ENST00000590798.1 | c.63+23010A>G | intron_variant | 2 | ENSP00000467286.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 0.00000548 AC: 8AN: 1460588Hom.: 0 Cov.: 32 AF XY: 0.00000275 AC XY: 2AN XY: 726690
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 30, 2024 | The c.259A>G (p.I87V) alteration is located in exon 4 (coding exon 4) of the ZNF700 gene. This alteration results from a A to G substitution at nucleotide position 259, causing the isoleucine (I) at amino acid position 87 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at